{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:10:18Z","timestamp":1777284618490,"version":"3.51.4"},"publisher-location":"Cham","reference-count":125,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030721428","type":"print"},{"value":"9783030721435","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/7854_2020_181","type":"book-chapter","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T21:11:43Z","timestamp":1612818703000},"page":"303-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New Pharmacological Interventions in Bipolar Disorder"],"prefix":"10.1007","author":[{"given":"Mario F.","family":"Juruena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke A.","family":"Jelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Cleare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"181_CR300","doi-asserted-by":"crossref","unstructured":"Adams WK, Levesque DL, Cocker PJ, Kaur S, Bodnar TS, Young AH, Winstanley CA (2020) Decreased motor impulsivity following chronic lithium treatment in male rats is associated with reduced levels of pro-inflammatory cytokines in the orbitofrontal cortex. Brain Behav Immun 89:339\u2013349","DOI":"10.1016\/j.bbi.2020.07.018"},{"key":"181_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","volume":"14","author":"A Anand","year":"2012","unstructured":"Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S (2012) Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial. Bipolar Disord 14:64\u201370","journal-title":"Bipolar Disord"},{"issue":"4","key":"181_CR2","first-page":"263","volume":"34","author":"AC Andreazza","year":"2009","unstructured":"Andreazza AC, Kapczinski F, Kauer-Sant\u2019Anna M, Walz JC, Bond DJ, Gon\u00e7alves CA et al (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34(4):263\u2013271","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"181_CR3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"AC Andreazza","year":"2010","unstructured":"Andreazza AC, Shao L, Wang JF, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67(4):360\u2013368","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"181_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","volume":"17","author":"S Arabzadeh","year":"2015","unstructured":"Arabzadeh S, Ameli N, Zeinoddini A, Rezaei F, Farokhnia M, Mohammadinejad P, Ghaleiha A, Akhondzadeh S (2015) Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial. Bipolar Disord 17(6):606\u2013614","journal-title":"Bipolar Disord"},{"key":"181_CR5","doi-asserted-by":"crossref","first-page":"360481","DOI":"10.1155\/2014\/360481","volume":"2014","author":"IG Barbosa","year":"2014","unstructured":"Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL (2014) Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014:360481","journal-title":"Neural Plast"},{"issue":"4","key":"181_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/wmts.51","volume":"1","author":"M Baudry","year":"2012","unstructured":"Baudry M, Greget R, Pernot F, Bouteiller JM, Xiaoning B (2012) Roles of group I metabotropic glutamate receptors under physiological conditions and in neurodegeneration. WIREs Membr Transp Signal 1(4):523\u2013532","journal-title":"WIREs Membr Transp Signal"},{"key":"181_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1871527317666181105162347","volume":"18","author":"DV Bavaresco","year":"2019","unstructured":"Bavaresco DV, Colonetti T, Grande AJ, Colom F, Valvassori SS, Quevedo J, da Rosa MI (2019) Efficacy of celecoxib adjunct treatment on bipolar disorder: systematic review and meta-analysis. CNS Neurol Disord Drug Targets 18:19\u201328","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"181_CR8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","volume":"17","author":"MC Bellingham","year":"2011","unstructured":"Bellingham MC (2011) A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17:4\u201331","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"181_CR9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","volume":"33","author":"M Beneyto","year":"2008","unstructured":"Beneyto M, Meador-Woodruff JH (2008) Lamina-specific abnormalities of NMDA receptor associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33(9):2175\u20132186","journal-title":"Neuropsychopharmacology"},{"key":"181_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468\u2013475","journal-title":"Biol Psychiatry"},{"key":"181_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","volume":"135","author":"M Berk","year":"2011","unstructured":"Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS (2011a) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135:389\u2013394","journal-title":"J Affect Disord"},{"issue":"3","key":"181_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al (2011b) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804\u2013817","journal-title":"Neurosci Biobehav Rev"},{"key":"181_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-019-1257-1","volume":"17","author":"M Berk","year":"2019","unstructured":"Berk M, Turner A, Malhi GS, Ng CH, Cotton SM, Dodd S, Samuni Y, Tanious M, McAulay C, Dowling N, Sarris J, Owen L, Waterdrinker A, Smith D, Dean OM (2019) A randomized controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med 17:18","journal-title":"BMC Med"},{"issue":"8","key":"181_CR15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.mp.4001111","volume":"7","author":"F Bosetti","year":"2002","unstructured":"Bosetti F, Rintala J, Seemann R, Rosenberger TA, Contreras MA, Rapoport SI, Chang MC (2002) Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry 7(8):845\u2013850","journal-title":"Mol Psychiatry"},{"key":"181_CR16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","volume":"32","author":"E Brietzke","year":"2008","unstructured":"Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1355\u20131361","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"181_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-5618.2001.030103.x","volume":"3","author":"ES Brown","year":"2001","unstructured":"Brown ES, Bobadilla L, Rush AJ (2001) Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. Bipolar Disord 3:23\u201329","journal-title":"Bipolar Disord"},{"key":"181_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pnpbp.2018.11.017","volume":"90","author":"JA Burket","year":"2019","unstructured":"Burket JA, Deutsch SI (2019) Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 90:142\u2013160","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"181_CR19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0006-3223(98)00320-5","volume":"45","author":"T Burt","year":"1999","unstructured":"Burt T, Sachs GS, Demopulos C (1999) Donepezil in treatment-resistant bipolar disorder. Biol Psychiatry 45:959\u2013964","journal-title":"Biol Psychiatry"},{"key":"181_CR20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-5618.2007.00507.x","volume":"9","author":"JR Calabrese","year":"2007","unstructured":"Calabrese JR, Guelfi JD, Perdrizet-Chevallier C, Agomelatine Bipolar Study Group (2007) Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 9:628\u2013635","journal-title":"Bipolar Disord"},{"key":"181_CR21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archpsyc.63.7.741","volume":"63","author":"DM Cannon","year":"2006","unstructured":"Cannon DM, Carson RE, Nugent AC, Eckelman WC, Kiesewetter DO, Williams J, Rollis D, Drevets M, Gandhi S, Solorio G, Drevets WC (2006) Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Arch Gen Psychiatry 63:741\u2013747","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"181_CR22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2012.10.036","volume":"148","author":"LA Carvalho","year":"2013","unstructured":"Carvalho LA, Torre JP, Papadopoulos AS, Poon L, Juruena MF, Markopoulou K, Cleare AJ, Pariante CM (2013) Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord 148(1):136\u2013140","journal-title":"J Affect Disord"},{"key":"181_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","volume":"9","author":"B Claustrat","year":"2005","unstructured":"Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9:11\u201324","journal-title":"Sleep Med Rev"},{"key":"181_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(03)00195-8","volume":"38","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157\u2013160","journal-title":"Neuron"},{"key":"181_CR25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","volume":"30","author":"CM Coyle","year":"2015","unstructured":"Coyle CM, Laws KR (2015) The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum Psychopharmacol 30:152\u2013163","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"181_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YPG.0b013e3283413382","volume":"21","author":"D Curtis","year":"2011","unstructured":"Curtis D, Vine AE, McQuillin A, Bass NJ, Pereira A, Kandaswamy R, Lawrence J, Anjorin A, Choudhury K, Datta SR, Puri V, Krasucki R, Pimm J, Thirumalai S, Quested D, Gurling HM (2011) Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes. Psychiatr Genet 21(1):1\u20134","journal-title":"Psychiatr Genet"},{"key":"181_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.1978.01770250121012","volume":"35","author":"KL Davis","year":"1978","unstructured":"Davis KL, Berger PA, Hollister LE, Defraites E (1978) Physostigmine in mania. Arch Gen Psychiatry 35:119\u2013122","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"181_CR28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","volume":"70","author":"C de la Fuente-Sandoval","year":"2013","unstructured":"de la Fuente-Sandoval C, Le\u00f3n-Ortiz P, Azc\u00e1rraga M, Stephano S, Favila R, D\u00edaz-Galvis L, Alvarado-Alanis P, Ram\u00edrez-Berm\u00fadez J, Graff-Guerrero A (2013) Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. JAMA Psychiat 70(10):1057\u20131066","journal-title":"JAMA Psychiat"},{"issue":"1","key":"181_CR29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","volume":"494","author":"RT de Sousa","year":"2011","unstructured":"de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, Forlenza OV, Gattaz WF, Machado-Vieira R (2011) Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 494(1):54\u201356","journal-title":"Neurosci Lett"},{"issue":"3","key":"181_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1525-139X.2001.00052.x","volume":"14","author":"B Descamps-Latscha","year":"2001","unstructured":"Descamps-Latscha B, Dr\u00fceke T, Witko-Sarsat V (2001) Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial 14(3):193\u2013199","journal-title":"Semin Dial"},{"key":"181_CR31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881114527361","volume":"28","author":"PR Diamond","year":"2014","unstructured":"Diamond PR, Farmery AD, Atkinson S, Haldar J, Williams N, Cowen PJ, Geddes JR, McShane R (2014) Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol 28:536\u2013544","journal-title":"J Psychopharmacol"},{"key":"181_CR32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793\u2013802","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"181_CR33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","volume":"13","author":"RC Drexhage","year":"2010","unstructured":"Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC et al (2010) Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 13(10):1369\u20131381","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"181_CR34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","volume":"48","author":"RS Duman","year":"2000","unstructured":"Duman RS, Malberg J, Nakagawa S, D\u2019as C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48(8):732\u2013739","journal-title":"Biol Psychiatry"},{"key":"181_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-5618.2006.00243.x","volume":"8","author":"A Eden Evins","year":"2006","unstructured":"Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G (2006) A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disord 8:75\u201380","journal-title":"Bipolar Disord"},{"issue":"6","key":"181_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1381612043453144","volume":"10","author":"FA Fitzpatrick","year":"2004","unstructured":"Fitzpatrick FA (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10(6):577\u2013588","journal-title":"Curr Pharm Des"},{"issue":"5","key":"181_CR37","first-page":"326","volume":"31","author":"BN Frey","year":"2006","unstructured":"Frey BN, Valvassori SS, R\u00e9us GZ, Martins MR, Petronilho FC, Bardini K et al (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31(5):326\u2013332","journal-title":"J Psychiatry Neurosci"},{"key":"181_CR38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","volume":"158","author":"T Fukumoto","year":"2001","unstructured":"Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 158:100\u2013106","journal-title":"Psychopharmacology"},{"key":"181_CR39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","volume":"63","author":"ML Furey","year":"2006","unstructured":"Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121\u20131129","journal-title":"Arch Gen Psychiatry"},{"key":"181_CR40","first-page":"CD005168","volume":"1","author":"P Gallagher","year":"2008","unstructured":"Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P (2008) Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev 1:CD005168","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"181_CR41","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.npp.1300201","volume":"28","author":"SE Gartside","year":"2003","unstructured":"Gartside SE, Leitch MM, Young AH (2003) Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 28(9):1572\u20131578","journal-title":"Neuropsychopharmacology"},{"issue":"9878","key":"181_CR42","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","volume":"381","author":"JR Geddes","year":"2013","unstructured":"Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381(9878):1672\u20131682","journal-title":"Lancet"},{"key":"181_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2008.11.015","volume":"116","author":"AS Gibbons","year":"2009","unstructured":"Gibbons AS, Scarr E, McLean C, Sundram S, Dean B (2009) Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects. J Affect Disord 116:184\u2013191","journal-title":"J Affect Disord"},{"issue":"1","key":"181_CR44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41380-019-0448-7","volume":"25","author":"VV Giridharan","year":"2019","unstructured":"Giridharan VV, Sayana P, Pinjari OF, Ahmad N, da Rosa MI, Quevedo J, Barichello T (2019) Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Mol Psychiatry 25(1):94\u2013113","journal-title":"Mol Psychiatry"},{"issue":"11","key":"181_CR45","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","volume":"152","author":"MJ Gitlin","year":"1995","unstructured":"Gitlin MJ, Swendsen J, Heller TL, Hammen C (1995) Relapse and impairment in bipolar disorder. Am J Psychiatry 152(11):1635\u20131640","journal-title":"Am J Psychiatry"},{"key":"181_CR46","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","volume":"171","author":"B Guardiola-Lemaitre","year":"2014","unstructured":"Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaer E (2014) Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol 171:3604\u20133619","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"181_CR47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","volume":"143","author":"S Guloksuz","year":"2012","unstructured":"Guloksuz S, Altinbas K, Aktas Cetin E, Kenis G, Bilgic Gazioglu S, Deniz G, Oral ET, van Os J (2012) Evidence for an association between tumor necrosis factor-alpha levels and lithium response. J Affect Disord 143(1\u20133):148\u2013152","journal-title":"J Affect Disord"},{"key":"181_CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2019.10.021","volume":"261","author":"A Halaris","year":"2020","unstructured":"Halaris A, Cantos A, Johnson K, Hakimi M, Sinacore J (2020) Modulation of the inflammatory response benefits treatment-resistant bipolar depression: a randomized clinical trial. J Affect Disord 261:145\u2013152","journal-title":"J Affect Disord"},{"key":"181_CR49","unstructured":"Hallahan B (n.d.) Scopolamine in bipolar depression (SCOPE-BD). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04211961"},{"issue":"7","key":"181_CR50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005053-197807000-00007","volume":"166","author":"NH Hendler","year":"1978","unstructured":"Hendler NH (1978) Spironolactone prophylaxis in manic-depressive disease. J Nerv Ment Dis 166(7):517\u2013520","journal-title":"J Nerv Ment Dis"},{"issue":"7","key":"181_CR51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0306-9877(81)90044-X","volume":"7","author":"DF Horrobin","year":"1981","unstructured":"Horrobin DF, Lieb J (1981) A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system. Med Hypotheses 7(7):891\u2013905","journal-title":"Med Hypotheses"},{"issue":"2","key":"181_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/YCT.0b013e3181c18bbf","volume":"26","author":"Y Hu","year":"2010","unstructured":"Hu Y, Yu X, Yang F, Si T, Wang W, Tan Y, Zhou D, Wang H, Chen D (2010) The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J ECT 26(2):121\u2013125","journal-title":"J ECT"},{"key":"181_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S115002","volume":"13","author":"MI Husain","year":"2016","unstructured":"Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JF, Husain N, Young AH (2016) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial. Neuropsychiatr Dis Treat 13:1\u20138","journal-title":"Neuropsychiatr Dis Treat"},{"key":"181_CR301","doi-asserted-by":"crossref","unstructured":"Husain MI, Strawbridge R, Stokes PR, Young AH (2017) Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis. J Psychopharmacol 31:1137\u20131148","DOI":"10.1177\/0269881117725711"},{"issue":"6","key":"181_CR54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","volume":"7","author":"MI Husain","year":"2020","unstructured":"Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, Naqvi HA, Minhas FA, Carvalho AF, Meyer JH, Deakin B, Mulsant BH, Husain N, Young AH (2020) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomized controlled trial. Lancet Psychiatry 7(6):515\u2013527","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"181_CR55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0891-5849(02)01197-8","volume":"34","author":"H Imai","year":"2003","unstructured":"Imai H, Nakagawa Y (2003) Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 34(2):145\u2013169","journal-title":"Free Radic Biol Med"},{"key":"181_CR56","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","volume":"2","author":"DS Janowsky","year":"1972","unstructured":"Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632\u2013635","journal-title":"Lancet"},{"key":"181_CR57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5607\/en.2014.23.1.28","volume":"23","author":"C Jun","year":"2014","unstructured":"Jun C, Choi Y, Lim SM, Bae S, Hong YS, Kim JE, Lyoo IK (2014) Disturbance of the glutamatergic system in mood disorders. Exp Neurobiol 23:28\u201335","journal-title":"Exp Neurobiol"},{"key":"181_CR58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yebeh.2013.10.020","volume":"38","author":"MF Juruena","year":"2014","unstructured":"Juruena MF (2014) Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav 38:148\u2013159","journal-title":"Epilepsy Behav"},{"issue":"8","key":"181_CR59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/0269881108092121","volume":"23","author":"MF Juruena","year":"2009","unstructured":"Juruena MF, Gama CS, Berk M, Belmonte-de-Abreu PS (2009) Improved residual symptoms in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series. J Psychopharmacol 23(8):985\u2013987","journal-title":"J Psychopharmacol"},{"key":"181_CR60","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1192\/bjp.bp.108.050278","volume":"194","author":"MF Juruena","year":"2009","unstructured":"Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ (2009a) Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Br J Psychiatry 194:342\u2013349","journal-title":"Br J Psychiatry"},{"key":"181_CR61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2008.10.012","volume":"33","author":"MF Juruena","year":"2009","unstructured":"Juruena MF, Ottoni G, Machado-Vieira R, Carneiro R, Weingarthner N, Fleig SS, Broilo L, Busnello ED (2009b) Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Prog Neuro-Psychopharmacol Biol Psychiatry 33:94\u201399","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"181_CR62","first-page":"w13880","volume":"144","author":"M Kargar","year":"2014","unstructured":"Kargar M, Yousefi A, Mojtahedzadeh M, Akhondzadeh S, Artounian V, Abdollahi A, Ahmadvand A, Ghaeli P (2014) Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study. Swiss Med Wkly 144:w13880","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"181_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200721010-00001","volume":"21","author":"T Kato","year":"2007","unstructured":"Kato T (2007) Mitochondrial dysfunction as themolecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21(1):1\u201311","journal-title":"CNS Drugs"},{"key":"181_CR64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e318184fae2","volume":"32","author":"PE Keck Jr","year":"2009","unstructured":"Keck PE Jr, Hsu HA, Papadakis K, Russo J Jr (2009) Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation. Clin Neuropharmacol 32:199\u2013204","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"181_CR65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"JN Kew","year":"2005","unstructured":"Kew JN, Kemp JA (2005) Ionotropic andmetabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179(1):4\u201329","journal-title":"Psychopharmacology"},{"key":"181_CR66","first-page":"680","volume":"5","author":"R Khairova","year":"2012","unstructured":"Khairova R, Pawar R, Salvadoran G, Juruena MF, De Sousa RT, Soeiro-de-Souza MG, Salvador M, Zarate CA, Gattaz WF, Machado-Vieira R (2012) Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep 5:680\u2013682","journal-title":"Mol Med Rep"},{"key":"181_CR67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-4159.2004.02725.x","volume":"91","author":"P Laeng","year":"2004","unstructured":"Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H, Thyagarajan R, Mallon BS, Altar CA (2004) The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238\u2013251","journal-title":"J Neurochem"},{"key":"181_CR68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2013.01.005","volume":"138","author":"L Lanfumey","year":"2013","unstructured":"Lanfumey L, Mongeau R, Hamon M (2013) Biological rhythms and melatonin in mood disorders and their treatments. Pharmacol Ther 138:176\u2013184","journal-title":"Pharmacol Ther"},{"issue":"2","key":"181_CR69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1528-1157.1991.tb05882.x","volume":"32","author":"MJ Leach","year":"1991","unstructured":"Leach MJ, Baxter MG, Critchley MA (1991) Neurochemical and behavioral aspects of lamotrigine. Epilepsia 32(2):4\u20138","journal-title":"Epilepsia"},{"issue":"1","key":"181_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","volume":"141","author":"M Leboyer","year":"2012","unstructured":"Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, Kupfer DJ (2012) Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 141(1):1\u201310","journal-title":"J Affect Disord"},{"key":"181_CR71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","volume":"34","author":"SY Lee","year":"2014","unstructured":"Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, Wang YS, Wang LJ, Lee IH, Wang TY, Yeh TL, Yang YK, Hong JS, Lu RB (2014) The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial. J Clin Psychopharmacol 34:337\u2013343","journal-title":"J Clin Psychopharmacol"},{"key":"181_CR72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0301-0082(03)00019-4","volume":"69","author":"V Lessmann","year":"2003","unstructured":"Lessmann V, Gottmann K, Malcangio M (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 69:341\u2013374","journal-title":"Prog Neurobiol"},{"issue":"1\u20133","key":"181_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00361-X","volume":"69","author":"X Li","year":"2002","unstructured":"Li X, Ketter TA, Frye MA (2002) Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord 69(1\u20133):1\u201314","journal-title":"J Affect Disord"},{"issue":"7","key":"181_CR74","doi-asserted-by":"crossref","first-page":"E2143","DOI":"10.3390\/ijms19072143","volume":"19","author":"F L\u00f3pez-Mu\u00f1oz","year":"2018","unstructured":"L\u00f3pez-Mu\u00f1oz F, Shen WW, D\u2019Ocon P, Romero A, \u00c1lamo C (2018) A history of the pharmacological treatment of bipolar disorder. Int J Mol Sci 19(7):E2143","journal-title":"Int J Mol Sci"},{"issue":"12","key":"181_CR75","doi-asserted-by":"crossref","first-page":"e1001359","DOI":"10.1371\/journal.pmed.1001359","volume":"9","author":"C Lund","year":"2012","unstructured":"Lund C, Tomlinson M, De Silva M, Fekadu A, Shidhaye R, Jordans M, Petersen I, Bhana A, Kigozi F, Prince M, Thornicroft G, Hanlon C, Kakuma R, McDaid D, Saxena S, Chisholm D, Raja S, Kippen-Wood S, Honikman S, Fairall L, Patel V (2012) Prime. A programme to reduce the treatment gap for mental disorders in five low- and middle-income countries. PLoS Med 9(12):e1001359","journal-title":"PLoS Med"},{"issue":"4","key":"181_CR76","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.pbb.2011.09.010","volume":"100","author":"R Machado-Vieira","year":"2012","unstructured":"Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA Jr (2012) Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol Biochem Behav 100(4):678\u2013687","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"181_CR77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):664\u2013675","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"181_CR78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","volume":"33","author":"PV Magalhaes","year":"2011","unstructured":"Magalhaes PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N-acetylcysteine for major depressive episodes in bipolar disorder. Braz J Psychiatry 33:374\u2013378","journal-title":"Braz J Psychiatry"},{"key":"181_CR79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jad.2017.06.044","volume":"221","author":"AR Mahableshwarkar","year":"2017","unstructured":"Mahableshwarkar AR, Calabrese JR, Macek TA, Budur K, Adefuye A, Dong X, Hanson E, Sachs GS (2017) Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: a phase 3, randomized controlled trial. J Affect Disord 221:275\u2013282","journal-title":"J Affect Disord"},{"issue":"12","key":"181_CR80","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","volume":"49","author":"GS Malhi","year":"2015","unstructured":"Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49(12):1087\u20131206","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"181_CR81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2006.09.011","volume":"1127","author":"RE McCullumsmith","year":"2007","unstructured":"McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007) Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127(1):108\u2013118","journal-title":"Brain Res"},{"key":"181_CR82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/YIC.0b013e3283400d35","volume":"26","author":"SL McElroy","year":"2011","unstructured":"McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE Jr (2011) A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. Int Clin Psychopharmacol 26:48\u201353","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"181_CR83","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/pr800892u","volume":"8","author":"GA McLoughlin","year":"2009","unstructured":"McLoughlin GA, Ma D, Tsang TM, Jones DN, Cilia J, Hill MD, Robbins MJ, Benzel IM, Maycox PR, Holmes E, Bahn S (2009) Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. J Proteome Res 8(4):1943\u20131952","journal-title":"J Proteome Res"},{"issue":"1\u20133","key":"181_CR84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","volume":"698","author":"A Mehta","year":"2013","unstructured":"Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 698(1\u20133):6\u201318","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"181_CR85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74(1):15\u201325","journal-title":"Biol Psychiatry"},{"key":"181_CR86","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/cap.2016.0207","volume":"27","author":"SY Mousavi","year":"2017","unstructured":"Mousavi SY, Khezri R, Karkhaneh-Yousefi MA, Mohammadinejad P, Gholamian F, Mohammadi MR, Zeinoddini A, Akhondzadeh S (2017) Randomized double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania. J Child Adolesc Psychopharmacol 27:494\u2013500","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"181_CR87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"S Moylan","year":"2013","unstructured":"Moylan S, Maes M, Wray N, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18:595\u2013606","journal-title":"Mol Psychiatry"},{"issue":"3","key":"181_CR88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0031-1291346","volume":"45","author":"H Murck","year":"2012","unstructured":"Murck H, Sch\u00fcssler P, Steiger A (2012) Renin-angiotensin-aldosterone system: the forgotten stress hormone system: relationship to depression and sleep. Pharmacopsychiatry 45(3):83\u201395","journal-title":"Pharmacopsychiatry"},{"key":"181_CR89","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"15","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539\u20137547","journal-title":"J Neurosci"},{"key":"181_CR90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2012.06.023","volume":"144","author":"ER Norris","year":"2013","unstructured":"Norris ER, Karen B, Correll JR, Zemanek KJ, Lerman J, Primelo RA, Kaufmann MW (2013) A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. J Affect Disord 144:141\u2013147","journal-title":"J Affect Disord"},{"issue":"2","key":"181_CR91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1979.tb10582.x","volume":"86","author":"PM O\u2019Brien","year":"1979","unstructured":"O\u2019Brien PM, Craven D, Selby C, Symonds EM (1979) Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 86(2):142\u2013147","journal-title":"Br J Obstet Gynaecol"},{"issue":"2\u20133","key":"181_CR92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.eplepsyres.2006.05.004","volume":"70","author":"GP Paraskevas","year":"2006","unstructured":"Paraskevas GP, Triantafyllou NI, Kapaki E, Limpitaki G, Petropoulou O, Vassilopoulos D (2006) Add-on lamotrigine treatment and plasma glutamate levels in epilepsy: relation to treatment response. Epilepsy Res 70(2\u20133):184\u2013189","journal-title":"Epilepsy Res"},{"key":"181_CR93","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000693","volume":"37","author":"LT Park","year":"2017","unstructured":"Park LT, Lener MS, Hopkins M, Iadorola N, Machado-Vieira R, Ballard E, Nugent A, Zarate CA Jr (2017) A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression. J Clin Psychopharmacol 37:355\u2013358","journal-title":"J Clin Psychopharmacol"},{"key":"181_CR94","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ijnp\/pyy018","volume":"21","author":"C Pereira","year":"2018","unstructured":"Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM (2018) Mitochondrial agents for bipolar disorder. Int J Neuropsychopharmacol 21:550\u2013569","journal-title":"Int J Neuropsychopharmacol"},{"key":"181_CR95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuropharm.2005.10.001","volume":"50","author":"T Rantamaki","year":"2006","unstructured":"Rantamaki T, Knuuttila JEA, Hokkanen ME, Castr\u00e9n E (2006) The effects of acute and long-term lithium treatments on TrkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology 50:421\u2013427","journal-title":"Neuropharmacology"},{"key":"181_CR96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1874467210902020207","volume":"2","author":"JS Rao","year":"2009","unstructured":"Rao JS, Rapoport SI (2009) Mood-stabilizers target the brain arachidonic acid cascade. Curr Mol Pharmacol 2:207\u2013214","journal-title":"Curr Mol Pharmacol"},{"issue":"6","key":"181_CR97","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mp.2008.31","volume":"13","author":"JS Rao","year":"2008","unstructured":"Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13(6):585\u2013596","journal-title":"Mol Psychiatry"},{"issue":"4","key":"181_CR98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","volume":"15","author":"JS Rao","year":"2010","unstructured":"Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4):384\u2013392","journal-title":"Mol Psychiatry"},{"issue":"3","key":"181_CR99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","volume":"50","author":"MH Rapaport","year":"2001","unstructured":"Rapaport MH, Manji HK (2001) The effects of lithium on ex vivo cytokine production. Biol Psychiatry 50(3):217\u2013224","journal-title":"Biol Psychiatry"},{"key":"181_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","volume":"140","author":"G Riedel","year":"2003","unstructured":"Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140:1\u201347","journal-title":"Behav Brain Res"},{"key":"181_CR101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1399-5618.2007.00532.x","volume":"9","author":"S Roitman","year":"2007","unstructured":"Roitman S, Green T, Osher Y, Karni N, Levine J (2007) Creatine monohydrate in resistant depression: a preliminary study. Bipolar Disord 9:754\u2013758","journal-title":"Bipolar Disord"},{"issue":"2","key":"181_CR102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2006.08.026","volume":"407","author":"AR Rosa","year":"2006","unstructured":"Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha AB, Quevedo J, Santin A, Gottfriend C, Gon\u00e7alves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407(2):146\u2013150","journal-title":"Neurosci Lett"},{"key":"181_CR103","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1017\/S0033291714000014","volume":"44","author":"AR Rosa","year":"2014","unstructured":"Rosa AR, Singh N, Whitaker E, de Brito M, Lewis AM, Vieta E, Churchill GC, Geddes JR, Goodwin GM (2014) Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels. Psychol Med 44:2409\u20132418","journal-title":"Psychol Med"},{"key":"181_CR105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","volume":"23","author":"T Saarelainen","year":"2003","unstructured":"Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasaio A, Nawa H, Aloyz EP, Castren E (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant induced behavioral effects. J Neurosci 23:349\u2013357","journal-title":"J Neurosci"},{"key":"181_CR106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4088\/JCP.10r06710","volume":"73","author":"J Sarris","year":"2012","unstructured":"Sarris J, Mischoulon D, Schweitzer I (2012) Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 73:81\u201386","journal-title":"J Clin Psychiatry"},{"key":"181_CR107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","volume":"8","author":"JB Savitz","year":"2018","unstructured":"Savitz JB, Teague TK, Misaki M, Macaluso M, Wurfel BE, Meyer M, Drevets D, Yates W, Gleason O, Drevets WC, Preskorn SH (2018) Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2x2 double-blind, randomized, placebo-controlled, phase IIA clinical trial. Transl Psychiatry 8:27","journal-title":"Transl Psychiatry"},{"issue":"5","key":"181_CR108","doi-asserted-by":"crossref","first-page":"e1111","DOI":"10.1038\/tp.2017.83","volume":"7","author":"G Scaini","year":"2017","unstructured":"Scaini G, Fries GR, Valvassori SS, Zeni CP, Zunta-Soares G, Berk M et al (2017) Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients. Transl Psychiatry 7(5):e1111","journal-title":"Transl Psychiatry"},{"key":"181_CR109","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","volume":"91","author":"N Scheefhals","year":"2018","unstructured":"Scheefhals N, MacGillavry HD (2018) Functional organization of postsynaptic glutamate receptors. Mol Cell Neurosci 91:82\u201394","journal-title":"Mol Cell Neurosci"},{"key":"181_CR110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2005.04.052","volume":"58","author":"L Shao","year":"2005","unstructured":"Shao L, Young LT, Wang JF (2005) Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58:879\u2013884","journal-title":"Biol Psychiatry"},{"key":"181_CR111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuropharm.2006.09.002","volume":"52","author":"M Sitges","year":"2007","unstructured":"Sitges M, Chiu LM, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52:598\u2013605","journal-title":"Neuropharmacology"},{"key":"181_CR112","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bdi.12496","volume":"19","author":"JK Soczynska","year":"2017","unstructured":"Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS (2017) A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I\/II depression. Bipolar Disord 19:198\u2013213","journal-title":"Bipolar Disord"},{"issue":"4","key":"181_CR113","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuroscience.2009.04.013","volume":"161","author":"N Sourial-Bassillious","year":"2009","unstructured":"Sourial-Bassillious N, Rydelius PA, Aperia A, Aizman O (2009) Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 161(4):1126\u20131134","journal-title":"Neuroscience"},{"key":"181_CR114","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pnpbp.2017.04.028","volume":"77","author":"A Tatay-Manteiga","year":"2017","unstructured":"Tatay-Manteiga A, Balanz\u00e1-Mart\u00ednez V, Bristot G, Tabar\u00e9s-Seisdedos R, Kapczinski F, Cauli O (2017) Clinical staging and serum cytokines in bipolar patients during euthymia. Prog Neuropsychopharmacol Biol Psychiatry 77:194\u2013201","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"181_CR115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00702-017-1817-5","volume":"125","author":"RA Toniolo","year":"2018","unstructured":"Toniolo RA, Silva M, Fernandes FBF, Amaral J, Dias RDS, Lafer B (2018) A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression. J Neural Transm 125:247\u2013257","journal-title":"J Neural Transm"},{"issue":"10","key":"181_CR116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","volume":"74","author":"M Wang","year":"1995","unstructured":"Wang M, Hammarb\u00e4ck S, Lindhe BA, B\u00e4ckstr\u00f6m T (1995) Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 74(10):803\u2013808","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"181_CR117","first-page":"523","volume":"11","author":"JF Wang","year":"2009","unstructured":"Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Hron 11(5):523\u2013529","journal-title":"Hron"},{"key":"181_CR118","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1192\/bjp.184.6.496","volume":"184","author":"S Watson","year":"2004","unstructured":"Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184:496\u2013502","journal-title":"Br J Psychiatry"},{"key":"181_CR119","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biopsych.2012.05.029","volume":"72","author":"S Watson","year":"2012","unstructured":"Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, North-East Mood Disorders Clinical Research Group, Young AH, Ferrier IN (2012) A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry 72:943\u2013949","journal-title":"Biol Psychiatry"},{"key":"181_CR120","first-page":"33","volume":"7","author":"H Wernze","year":"2000","unstructured":"Wernze H (2000) Surprising effect of spironolactone on eating behavior and mood in bulimia nervosa. Psychopharmakotherapie 7:33\u201339","journal-title":"Psychopharmakotherapie"},{"key":"181_CR121","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1192\/bjp.bp.114.147587","volume":"208","author":"LN Yatham","year":"2016","unstructured":"Yatham LN, Vieta E, Goodwin GM, Bourin M, de Bodinat C, Laredo J, Calabrese J, Agomelatine Study Group (2016) Agomelatine or placebo as adjunctive therapy to a mood stabilizer in bipolar I depression: randomized double-blind placebo-controlled trial. Br J Psychiatry 208:78\u201386","journal-title":"Br J Psychiatry"},{"key":"181_CR122","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/npp.2009.2","volume":"34","author":"SJ Yoon","year":"2009","unstructured":"Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF (2009) Decreased glutamate\/glutamine levels may mediate cytidine\u2019s efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology 34:1810\u20131818","journal-title":"Neuropsychopharmacology"},{"key":"181_CR123","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","volume":"29","author":"AH Young","year":"2004","unstructured":"Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (2004) Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29:1538\u20131545","journal-title":"Neuropsychopharmacology"},{"key":"181_CR224","unstructured":"Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK (2005) An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57(4):430\u2013432"},{"issue":"11","key":"181_CR124","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2012","unstructured":"Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA (2012) Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71(11):939\u2013946","journal-title":"Biol Psychiatry"}],"container-title":["Current Topics in Behavioral Neurosciences","Bipolar Disorder: From Neuroscience to Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2020_181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T15:25:05Z","timestamp":1617031505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2020_181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030721428","9783030721435"],"references-count":125,"URL":"https:\/\/doi.org\/10.1007\/7854_2020_181","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"6 February 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}